TY - JOUR
T1 - An Indonesian female with severe cutaneous lupus erythematosus
T2 - A case report and literature review
AU - Hadisuwarno, Wiharjo
AU - Rahmawati, Lita Diah
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/6
Y1 - 2023/6
N2 - Introduction: Cutaneous lupus erythematosus (CLE) is one of the most common symptoms in systemic lupus erythematosus (SLE) cases. SLE manifestations in the skin area seem to significantly affect the patient's quality of life, which is this condition for unmarried females. Case presentation: An Indonesian female, 23 years old, complained of skin peeling on her scalp, upper and lower extremities. The condition of the wound was severe in the head area. A biopsy was performed, revealing pustular psoriasis. She received immunosuppressant agent and wound care over the lesion. The patient showed good improvement after 2 weeks of this treatment. Discussion: Diagnosis of CLE through history taking, skin examination and histopathological findings. Since immunosuppressant agent is the primary therapy of CLE, monitoring is required because immunosuppressive drugs increase the risks of infection. The outcome of CLE treatment is to minimize complications and improve the patient's quality of life. Conclusion: CLE primarily affects women, therefore early management, monitoring and collaboration with other departments will improve the patient's quality of life and increase their compliance with medication.
AB - Introduction: Cutaneous lupus erythematosus (CLE) is one of the most common symptoms in systemic lupus erythematosus (SLE) cases. SLE manifestations in the skin area seem to significantly affect the patient's quality of life, which is this condition for unmarried females. Case presentation: An Indonesian female, 23 years old, complained of skin peeling on her scalp, upper and lower extremities. The condition of the wound was severe in the head area. A biopsy was performed, revealing pustular psoriasis. She received immunosuppressant agent and wound care over the lesion. The patient showed good improvement after 2 weeks of this treatment. Discussion: Diagnosis of CLE through history taking, skin examination and histopathological findings. Since immunosuppressant agent is the primary therapy of CLE, monitoring is required because immunosuppressive drugs increase the risks of infection. The outcome of CLE treatment is to minimize complications and improve the patient's quality of life. Conclusion: CLE primarily affects women, therefore early management, monitoring and collaboration with other departments will improve the patient's quality of life and increase their compliance with medication.
KW - Autoimmune disease
KW - Cutaneous lupus erythematosus
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=85159669572&partnerID=8YFLogxK
U2 - 10.1016/j.ijscr.2023.108336
DO - 10.1016/j.ijscr.2023.108336
M3 - Article
AN - SCOPUS:85159669572
SN - 2210-2612
VL - 107
JO - International Journal of Surgery Case Reports
JF - International Journal of Surgery Case Reports
M1 - 108336
ER -